Literature DB >> 15340360

Molecular diversity at the CYP2D6 locus in the Mediterranean region.

Silvia Fuselli1, Isabelle Dupanloup, Elena Frigato, Fulvio Cruciani, Rosaria Scozzari, Pedro Moral, Johanna Sistonen, Antti Sajantila, Guido Barbujani.   

Abstract

Despite the importance of cytochrome P450 in the metabolism of many drugs, several aspects of molecular variation at one of the main loci coding for it, CYP2D6, have never been analysed so far. Here we show that it is possible to rapidly and efficiently genotype the main European allelic variants at this locus by a SNaPshot method identifying chromosomal rearrangements and nine single-nucleotide polymorphisms. Haplotypes could be reconstructed from data on 494 chromosomes in six populations of the Mediterranean region. High levels of linkage disequilibrium were found within the chromosome region screened, suggesting that CYP2D6 may be part of a genomic recombination block, and hence that, aside from unequal crossingover that led to large chromosomal rearrangements, its haplotype diversity essentially originated through the accumulation of mutations. With the only, albeit statistically insignificant, exception of Syria, haplotype frequencies do not differ among the populations studied, despite the presence among them of three well-known genetic outliers, which could be the result of common selective pressures playing a role in shaping CYP2D6 variation over the area of Europe that we surveyed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340360     DOI: 10.1038/sj.ejhg.5201243

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  5 in total

1.  BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.

Authors:  Caterina Chianella; Daniela Gragnaniello; Pierpaolo Maisano Delser; Maria Francesca Visentini; Elisabetta Sette; Maria Rosaria Tola; Guido Barbujani; Silvia Fuselli
Journal:  Eur J Clin Pharmacol       Date:  2011-06-01       Impact factor: 2.953

Review 2.  Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.

Authors:  Shabbir Ahmed; Zhan Zhou; Jie Zhou; Shu-Qing Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-10-08       Impact factor: 7.691

Review 3.  Frequencies of CYP2D6 genetic polymorphisms in Arab populations.

Authors:  Mousa Alali; Wouroud Ismail Al-Khalil; Sara Rijjal; Lana Al-Salhi; Maher Saifo; Lama A Youssef
Journal:  Hum Genomics       Date:  2022-02-05       Impact factor: 4.639

Review 4.  Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.

Authors:  Yitian Zhou; Volker M Lauschke
Journal:  Hum Genet       Date:  2021-10-15       Impact factor: 5.881

5.  Influence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancer.

Authors:  Mercedes Zafra-Ceres; Tomas de Haro; Esther Farez-Vidal; Isabel Blancas; Fernando Bandres; Eduardo Martinez de Dueñas; Enrique Ochoa-Aranda; Jose A Gomez-Capilla; Carolina Gomez-Llorente
Journal:  Int J Med Sci       Date:  2013-05-27       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.